1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Procedure characteristics
Kyphoplasty (n = 191) Vertebroplasty (n = 190) P Value Surgery as randomized (No.) 191 190 Physician type (m) (%) .019 Interventional radiologist 117 (61.3) 138 (72.6) Interventional neuroradiologist 33 (17.3) 27 (14.2) Orthopedic surgeon 41 (21.5) 23 (12.1) Neurosurgeon 0 2 (1.1) Anesthesia (m) (%) .086 Local with conscious sedation 125 (65.4) 143 (75.3) General 55 (28.8) 37 (19.5) Other 11 (5.8) 10 (5.3) Hospitalization (m) (%) .014 Outpatient 109 (57.1) 132 (69.5) Inpatient 82 (42.9) 58 (30.5) Postural reduction performed (m) (%) 154 (80.6) 142 (75.1) .217 Procedure duration (min) (mean) (SD) 40.0 (22.0) 31.8 (19.3) <.001 Fluoroscopy duration (min) (mean) (SD) 10.0 (6.3) 8.5 (4.9) .008 Duration of stay (hr) (median) (IQR) 22.0 (6.0–26.0) 8.0 (5.0–24.0) .010 Fractures treated n = 244 n = 235 Procedure (m) (%) <.001 Bilateral 242 (99.2) 151 (65.1) Unilateral 2 (0.8) 81 (34.9) Total cement volume (mL) (median) (IQR)a 4.6 (3.4–6.0) 4.0 (3.0–6.0) .053 Fractures scanned by CTb n = 214 n = 201 Vertebral body volume (mL) (median) (IQR) 25.7 (19.3–31.4) 25.1 (19.4–31.9) .74 Cement volume (mL) (median) (IQR) 5.2 (3.8–6.3) 4.6 (2.9–6.5) .037 Cement/vertebral ratio (median) (IQR) 0.21 (0.16–0.26) 0.19 (0.13–0.25) .008
Note:—(m) indicates numerator (No.) in category; IQR, interquartile range.
↵a For BKP, all patients were treated with HV-R bone cement (Kyphon; Medtronic Spine, Sunnyvale, California). For VP, 46 (24.3%) patients were treated with Spineplex (Stryker, Kalamazoo, Michigan); 43 (22.8%), with Parallax (ArthroCare, Austin, Texas); 34 (18.0%), with AVAtex (CareFusion, San Diego, California); 14 (7.4%), with Confidence (DePuy Spine, Raynham, Massachusetts); 11 (5.8%), with HV-R (Kyphon); 10 (5.3%), with Visioplast (Tecres, Verona, Italy); and 10 (5.3%), with Vertefix (Cook, Bloomington, Indiana). The remaining 21 (11.1%) were treated with other bone cements.
↵b CT assessments were made by the core radiographic laboratory.